Delivery Order SPE2DR25D1004-SPE2DR26FSWJ2
- Not listed
- The Defense Logistics Agency awarded a $4,116.30 firm fixed price delivery order to AmerisourceBergen Drug Corp for EMGALITY 120 mg/ml pen medication, with performance in Conshohocken, Pennsylvania. The award was made on December 4, 2025, with an ultimate completion date of December 5, 2025, and was not designated as a set-aside contract. This delivery order represents a single transactional purchase under AmerisourceBergen's broader federal pharmaceutical supply agreements. This award is a...
- The Defense Logistics Agency awarded a delivery order valued at $1,729.00 to AmerisourceBergen Drug Corp for EMGALITY 120 mg/mL in pen format, a migraine treatment medication. This firm fixed-price delivery order, issued on August 20, 2025, with an ultimate completion date of August 21, 2025, represents a small-value transaction under AmerisourceBergen's existing contract vehicle with DLA. The award was made on a competitive, non-set-aside basis, reflecting open competition in federal...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,113.47 firm fixed-price contract is for the delivery of EMGALITY 120 MG/ML PENML, a pharmaceutical product, with a completion date of January 27, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,823.76 firm fixed-price delivery order is for the supply of EMGALITY 120 MG/ML PENML, a pharmaceutical product. The contract has an ultimate completion date of June 25, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a $1,836.98 firm fixed price delivery order to AmerisourceBergen Drug Corp for Emgality 120 mg/ml pens on October 30, 2025, with completion by October 31, 2025. This non-competitive delivery order represents a single pharmaceutical product transaction under AmerisourceBergen's existing contract vehicles with DLA. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical supplier to the federal medical supply chain and is...
- The Defense Logistics Agency awarded a delivery order valued at $5,187.45 to AmerisourceBergen Drug Corp for Emgality 120 mg/ml pen medication on September 24, 2025, with completion scheduled for September 25, 2025. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion pharmaceutical supply vehicle running through December 2026. The award was made on a firm fixed price basis...
- The U.S. government agency Defense Logistics Agency (DLA) awarded a $1,729.00 firm fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract covers the supply of EMGALITY 120 MG/ML PENML, a pharmaceutical product, with a period of performance through February 18, 2025. This contract award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,008.80 for Emgality 120 mg/ml pen injectors on November 14, 2025, with completion expected by November 17, 2025. This firm fixed price, non-set-aside contract was awarded competitively and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a discrete purchase under AmerisourceBergen's broader contracting relationship with DLA...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide EMGALITY 120 MG/ML PENML pharmaceutical products. The order has a potential value of $1,018.15 and a completion date of January 19, 2024. No set-aside designation was used for this award. Amerisourcebergen Drug Corp is a prime contractor that has received multiple federal contracts from DLA Troop...
- The Defense Logistics Agency awarded a $2,008.80 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Emgality 120 mg/mL pen medication, with an ultimate completion date of October 21, 2025. This non-set-aside, competitively awarded contract represents a pediatric delivery supporting federal medical supply requirements. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this delivery from its corporate office...
- SPE2DR25D1004Indefinite Delivery Contract
- SPE2DR25D1004-SPE2DR26FSWJ2Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,627.12 to AmerisourceBergen Drug Corp for EMGALITY 120 mg/ml pen medication, effective December 10, 2025, with an ultimate completion date of December 11, 2025. This competitively awarded, firm fixed-price delivery order was placed against AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, fulfills this delivery order as part of its comprehensive pharmaceutical support obligations under the SPE2DX prime IDC. This vehicle enables the company to supply a broad spectrum of pharmaceutical products and medical commodities to support military healthcare programs globally, serving customers including the Defense Health Agency and U.S. Coast Guard. The award demonstrates AmerisourceBergen's ongoing role in the pharmaceutical supply chain supporting Department of Defense medical needs through the DLA Medical Supply Chain infrastructure.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.6k | 12/9/25 |